Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis.
作者： Ø Fluge , , K Gravdal , E Carlsen , B Vonen
关键词:
摘要: Background: Enhancer of zeste homologue 2 (EZH2) is a member of the Polycomb group of genes that is involved in epigenetic silencing and cell cycle regulation. Methods: We studied …
nature.com
utsystem.edu
researchgate.net 
core.ac.uk 参考文章(19)
Johan van der Vlag, Arie P. Otte, Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nature Genetics. ,vol. 23, pp. 474- 478 ,(1999) , 10.1038/70602
Carmen J Allegra, Soon Paik, Linda H Colangelo, Allyson L Parr, Ilan Kirsch, George Kim, Pamela Klein, Patrick G Johnston, Norman Wolmark, H Samuel Wieand, None, Prognostic Value of Thymidylate Synthase, Ki-67, and p53 in Patients With Dukes’ B and C Colon Cancer: A National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project Collaborative Study Journal of Clinical Oncology. ,vol. 21, pp. 241- 250 ,(2003) , 10.1200/JCO.2003.05.044
Olav Dahl, Øystein Fluge, Erik Carlsen, Johan N. Wiig, Helge E. Myrvold, Barthold Vonen, Nina Podhorny, Ottar Bjerkeset, Tor Jack Eide, Tore B. Halvorsen, Kjell Magne Tveit, , Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group Acta Oncologica. ,vol. 48, pp. 368- 376 ,(2009) , 10.1080/02841860902755244
D C Brown, K C Gatter, Ki67 protein: the immaculate deception? Histopathology. ,vol. 40, pp. 2- 11 ,(2002) , 10.1046/J.1365-2559.2002.01343.X
Jan P. A. Baak, Einar Gudlaugsson, Ivar Skaland, Lydia Hui Ru Guo, Jan Klos, Tone Hoel Lende, Håvard Søiland, Emiel A. M. Janssen, Axel zur Hausen, Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers Breast Cancer Research and Treatment. ,vol. 115, pp. 241- 254 ,(2009) , 10.1007/S10549-008-0126-Y
N. Wolmark, B. Fisher, H. Rockette, C. Redmond, D. L. Wickerham, E. R. Fisher, J. Jones, A. Glass, H. Lerner, W. Lawrence, D. Prager, M. Wexler, J. Evans, A. Cruz, N. Dimitrov, P. Jochimsen, , Postoperative Adjuvant Chemotherapy or BCG for Colon Cancer: Results From NSABP Protocol C-011 JNCI Journal of the National Cancer Institute. ,vol. 80, pp. 30- 36 ,(1988) , 10.1093/JNCI/80.1.30
Aimery de Gramont, Christophe Tournigand, Thierry André, Annette K. Larsen, Christophe Louvet, Adjuvant therapy for stage II and III colorectal cancer. Seminars in Oncology. ,vol. 34, ,(2007) , 10.1053/J.SEMINONCOL.2007.01.004
Xiaohu Tang, Michael Milyavsky, Igor Shats, Neta Erez, Naomi Goldfinger, Varda Rotter, Activated p53 suppresses the histone methyltransferase EZH2 gene Oncogene. ,vol. 23, pp. 5759- 5769 ,(2004) , 10.1038/SJ.ONC.1207706
R Palmqvist, P Sellberg, Å Öberg, B Tavelin, J N Rutegård, R Stenling, Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers. British Journal of Cancer. ,vol. 79, pp. 577- 581 ,(1999) , 10.1038/SJ.BJC.6690091
R.J. Bryant, N.A. Cross, C.L. Eaton, F.C. Hamdy, V.T. Cunliffe, EZH2 promotes proliferation and invasiveness of prostate cancer cells. The Prostate. ,vol. 67, pp. 547- 556 ,(2007) , 10.1002/PROS.20550